Fibroblast Growth Factor 21 and Cardiometabolic Risk Markers in Metabolically Healthy and Unhealthy Obese Children
FGF21 levels were elevated in children with MUO compared with children with MHO and healthy controls. However, FGF21 does not appear to be a reliable biomarker. Further studies are required to clarify this relationship.
Authors
- Berrak Güven (ORCID: https://orcid.org/0000-0003-4073-3164)
- Zühal Örnek (ORCID: https://orcid.org/0000-0001-9252-1652)
- Banu Alıcıoğlu (ORCID: https://orcid.org/0000-0002-6334-7445)
- Can Kurşun
Institutions
- Zonguldak Bülent Ecevit University (TR)
- Nevşehir Hacı Bektaş Veli University (TR)
Publication Details
- Journal
- Journal of Paediatrics and Child Health
- Published
- 2026-03-26
- DOI
- https://doi.org/10.1111/jpc.70375
- Primary Topic
- Fibroblast Growth Factor Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00